IL13 and metabolic syndrome: Hyperglycemia and hypertriglyceridemia appear to be strongly linked to the increase in IL-13, which suggest a novel role of this cytokine in the regulation of glucagon-dependent pathways and lipolysis that should be addressed in patients at higher cardiovascular risk such as the vast majority of individuals living with insulin resistance, metabolic syndrome, and T2D.